Motzer and colleagues present updated results from a multicenter, phase III trial of sunitinib versus interferon-α as first-line treatment for patients with metastatic renal-cell carcinoma.
Demonstrating the treatment, the nurse handed her a nebuliser that makes the drug into a fine mist, which Alexandra inhaled as deep into her lungs as she could. Interferon beta is part of the body ...
Given that, researchers figured that a drug that suppresses interferon action might be able to treat Sjögren’s. Baricitinib is a JAK inhibitor, a class of drugs that suppress immune system signals in ...
reaffirms its enduring commitment to creating robust and reliable access to critical interferon therapies. Amidst growing global concerns about drug shortages of other therapies, PharmaEssentia ...